Atlas Trials

A Two-week Study Assessing the Onset of Effect Questionnaire (OEQ) Administered Daily Versus Weekly in Adult Subjects

Clinical trial NCT00449527 · COMPLETED

Trial details

NCT number
NCT00449527
Sponsor
AstraZeneca
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Asthma
Start date
2007-03-01
Enrollment
123

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.